Abstract
Wolfram syndrome, a rare genetic disorder is characterized by juvenile onset diabetes mellitus and optic atrophy. We describe two cases of wolfram syndrome belonging to same family; 25 year old female and her only 15 year old brother. In female, diabetes mellitus and optic atrophy were manifested in 1st decade, diabetes insipidus in 2nd decade and hypoacusis at the age of 25 years. Her ophthalmic evaluation revealed bilateral optic atrophy, decreased vision and peripheral constriction of visual field. However she didn’t have any renal dysfunction which is also considered to be one of the features of the syndrome. Though associated psychiatric features are later manifestations of the syndrome she was admitted with alleged suicidal consumption at the age of 25 years. The brother was asymptomatic except for the diabetes mellitus and insipidus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, Poulton J, et al. Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 1999; 65: 1279–1290.
Rando TA, Horton JC, Layzer RC. Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurol 1992; 42: 1220–1224.
Hofmann S, Philbrook C, Gerbitz KD, Bauer MF. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 2003; 12: 2003–2012.
Barrett TG, Bunday SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346: 1458–1463.
Cryns K, Sivakumaran TA, Van den Ouweland JM, Pennings RJ, Cremers CW, Flothmann K, et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003; 22(4): 275–287.
Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, Mueckler M. Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem 2003; 278(52): 52755–52762.
Hofmann S, Bauer MF. Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin. FEBS Lett 2006; 580(16): 4000–4004.
Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K, DeWan AT, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001; 10(22): 2501–2508.
Cryns K, Pfister M, Pennings RJ, Bom SJ, Flothmann K, Caethoven G, et al. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small noninactivating mutations. Hum Genet 2002; 110(5): 389–394.
Cryns K, Thys S, Van Laer L, Oka Y, Pfister M, Van Nassauw L, et al The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem Cell Biol 2003; 119(3): 247–256.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valsalan, R., gonsalves, H., Mailankot, M. et al. Wolfram syndrome — clinical and diagnostic details. Indian J Clin Biochem 24, 436–438 (2009). https://doi.org/10.1007/s12291-009-0079-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-009-0079-x